KR102334283B9 - 신규한 트랜스글루타미나제 2 억제제 및 이의 용도 - Google Patents
신규한 트랜스글루타미나제 2 억제제 및 이의 용도Info
- Publication number
- KR102334283B9 KR102334283B9 KR1020200070476A KR20200070476A KR102334283B9 KR 102334283 B9 KR102334283 B9 KR 102334283B9 KR 1020200070476 A KR1020200070476 A KR 1020200070476A KR 20200070476 A KR20200070476 A KR 20200070476A KR 102334283 B9 KR102334283 B9 KR 102334283B9
- Authority
- KR
- South Korea
- Prior art keywords
- transglutaminase
- noble
- inhibitors
- noble transglutaminase
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200070476A KR102334283B1 (ko) | 2020-06-10 | 2020-06-10 | 신규한 트랜스글루타미나제 2 억제제 및 이의 용도 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200070476A KR102334283B1 (ko) | 2020-06-10 | 2020-06-10 | 신규한 트랜스글루타미나제 2 억제제 및 이의 용도 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR102334283B1 KR102334283B1 (ko) | 2021-12-03 |
KR102334283B9 true KR102334283B9 (ko) | 2023-03-23 |
Family
ID=78866702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200070476A KR102334283B1 (ko) | 2020-06-10 | 2020-06-10 | 신규한 트랜스글루타미나제 2 억제제 및 이의 용도 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102334283B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022197069A1 (ko) * | 2021-03-16 | 2022-09-22 | 주식회사 엠디바이오랩 | 트랜스글루타미나제-2 활성을 저해하는 신규 화합물 및 이의 용도 |
KR102674225B1 (ko) * | 2021-03-16 | 2024-06-11 | (주)엠디바이오팜 | 트랜스글루타미나제-2 활성 억제용 벤조이미다졸 유도체 및 이를 함유하는 암 예방 또는 치료용 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101643459B1 (ko) | 2014-07-15 | 2016-07-28 | 국립암센터 | 스트렙토니그린을 포함하는 트랜스글루타미나제2 관련 질환 치료 또는 예방용 약제학적 조성물 및 이의 용도 |
-
2020
- 2020-06-10 KR KR1020200070476A patent/KR102334283B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR102334283B1 (ko) | 2021-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288381A (en) | Tead inhibitors and their uses | |
IL288384A (en) | Tead inhibitors and their uses | |
SI3966207T1 (sl) | Fenilaminopirimidinamidni zaviralci avtofagije in načini njihove uporabe | |
EP1512396A4 (en) | INHIBITORS OF AP-1 AND NFAT ACTIVATION | |
EP1931205A4 (en) | TRANSGLUTAMINASE INHIBITORS AND METHOD OF USE THEREOF | |
IL289612A (en) | hpk1 inhibitors and uses thereof | |
AU2003303128A8 (en) | Inhibitors and methods of use thereof | |
IL172471A0 (en) | Gsk-3 inhibitors and uses thereof | |
ZA202106202B (en) | Nanosensors and use thereof | |
IL286248A (en) | tyk2 inhibitors and their use | |
IL307187A (en) | MK2 inhibitors and their uses | |
KR102334283B9 (ko) | 신규한 트랜스글루타미나제 2 억제제 및 이의 용도 | |
EP3860636A4 (en) | MATRIPTASE-2 INHIBITORS AND USES THEREOF | |
IL300107A (en) | HSD17B13 quinazolinone inhibitors and uses thereof | |
IS7385A (is) | Fjölgervingar klópídógrelhýdróklóríðs og notkun þeirra sem andsegaefnasambanda | |
IL287973A (en) | acss2 inhibitors and methods of their use | |
GB202106282D0 (en) | Composition and use thereof | |
IL308759A (en) | Checkpoint kinase 1 (CHK1) inhibitors and uses thereof | |
IL291217A (en) | usp30 inhibitors and their uses | |
PT3677266T (pt) | Inibidor seletivo de egfr com mutação no exão 18 e/ou exão 21 | |
IL285595A (en) | Spt5 inhibitors and uses thereof | |
IL312466A (en) | PI3K-alpha inhibitors and methods for their preparation and use | |
SG11202012241RA (en) | Erk inhibitor and use thereof | |
IL286485A (en) | pi4-kinase inhibitors and methods of using them | |
EP4061341A4 (en) | CASPASE6 INHIBITORS AND USES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] |